BD announced that it appointed medtech veteran Dr. Joanne Waldstreicher to its board of directors. Waldstreicher most recently served as chief medical officer at Johnson & Johnson . She held that position from 2012 until her retirement in 2023. As CMO, she provided strategic and operational leadership with responsibility for safety, epidemiology, regulatory and clinical […]
BD
FDA clears updated BD Alaris infusion system after long-term commercial hold
BD announced today that the FDA granted 510(k) clearance for its updated Alaris infusion system. Shares of BDX closed out Friday evening priced at $264.84 each. They ticked up significantly after market close on the back of the Alaris news, rising 5.9% to $280.40 apiece. Clearance enables both remediation and a return to full commercial […]
8 drug delivery innovations you should know
Innovations in drug delivery never stop, and over the past 12 months or so a wide variety have been in the spotlight. Constant progress continues in the diabetes space, both in the form of insulin delivery and other drug delivery methods. Elsewhere, we see implants, patches, syringes and more showcasing the many ways we can […]
BD discloses 8 cybersecurity vulnerabilities with Alaris infusion system
BD today voluntarily posted a product security bulletin for a number of vulnerabilities with its Alaris infusion system. Franklin Lakes, New Jersey-based BD recently identified eight vulnerabilities. These vulnerabilities are associated with the BD Alaris system with Guardrails Suite MX, versions 12.1.3 and earlier. The company discovered the vulnerabilities through routine internal security testing as […]
BD is cutting 60 jobs at Ireland facility
BD announced plans to eliminate 60 positions at its manufacturing facility based in Drogheda, Ireland. A statement provided by a BD spokesperson confirmed a targeted reduction of 60 positions due to a combination of factors. These include the effects of the COVID-19 pandemic and the company’s spinoff of its diabetes business, Embecta. The company announced […]
Brooke Story to become president of Surgery business at BD
BD announced today that it named Brooke Story president of its Surgery business unit. Story’s responsibilities include driving the strategic, operational and commercial performance of the business unit. She reports to Rick Byrd, EVP and president of the Interventional segment at BD. The move for Story, who currently serves as president of the Integrated Diagnostic […]
BD sells surgical instrumentation assets to Steris for $540M
BD announced today that it signed a definitive agreement to sell its surgical instrumentation platform to Steris (NYSE:STE) for $540 million. The divestiture includes V. Mueller, Snowden-Pencer and Genesis branded products. BD reports its surgical instrumentation platform as part of its Surgery unit within its Interventional segment. In the deal, Steris also gets three manufacturing […]
The top IVD innovation news stories of 2023 — so far
This year is proving to be another important year for innovation in the in vitro diagnostic (IVD) space. According to the FDA, IVD devices are tests performed on samples taken from the human body. They could be everything from blood tests processed in labs to home COVID-19 or pregnancy tests to continuous glucose monitors using […]
BD wants to increase education on sexually transmitted infections
Earlier this year, BD shared results from a survey of more than 1,000 U.S. women found significant discrepancies in education around sexually transmitted infections (STIs). Of these women, over 18 years old, 77% identified as knowledgeable about vaginal infections, including yeast infections. However, only 60% said they felt knowledgeable about treatment options for these infections […]
BD continues to expand in Ireland
BD announced that it opened a new facility in Ireland and committed a further investment within the country. Last week, the company held a grand opening ceremony for a new $4.3 million (€4 million) R&D facility in Blackrock, Dublin. BD also announced an additional $32.1 million (€30 million) investment to expand its Enniscorthy, Wexford manufacturing […]
BD expands availability of all-in-one flush pre-filled syringe
BD (NYSE:BDX) announced today that it expanded customer availability for its all-in-one pre-filled flush syringe. Franklin Lakes, New Jersey-based BD designed its PosiFlush SafeScrub syringe with an integrated disinfection unit. It reinforces compliance to infection prevention guidelines, simplifying nursing workflow. BD built the active disinfection unit right into the tip cap of the PosiFlush SafeScrub […]